Silver Spring, Maryland–(ENEWSPF)–September 16, 2014. The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
FDA Approves Movantik for Opioid-induced Constipation
More in Health and Fitness:
